ArticleFrontiers in oncology2025
Global, regional and national burden of colorectal cancer and its risk factors, 1990-2021: a systematic analysis for the GBD 2021.
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- A Prospective Case-Control Study of Helicobacter pylori and Systemic Inflammation in Colorectal Cancer Pathogenesis.Cureus · 2026Article
- Integrated NGS and ddPCR analysis of RAS/RAF mutations in metastatic colorectal cancer among Kazakhstani patients: a pilot study.Frontiers in medicine · 2026Article
- National and Subnational Burden of Female Breast Cancer in Iran from 2010 to 2021.Diseases (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Importance: Colorectal cancer (CRC) constitutes a significant segment of the global cancer burden, thereby warranting an in-depth epidemiological appraisal to inform strategic public health interventions and resource allocation. Previous studies, such as those based on the GBD 2019 dataset, have provided valuable insights into the CRC burden. However, they have limitations in terms of data recency, regional granularity, and comprehensive risk factor analysis. Objective: This research seeks to undertake a thorough analysis of the burden of CRC at global, regional, and national levels, along with its associated risk factors, spanning the period from 1990 to 2021. This analysis will employ data sourced from the Global Burden of Disease (GBD) 2021 study, addressing limitations in previous research by providing a more detailed and updated assessment. Methods: We assessed the distribution of CRC across 204 countries and territories, focusing on age, gender, and geographic variations. The impact of key risk factors (including behavioral risks, metabolic risks, behavioral risks, metabolic risks) on disability-adjusted life years (DALYs) was evaluated across 21 GBD regions. A Bayesian age-period-cohort (BAPC) model was employed to project CRC trends over the next three decades. Findings: In 2021, global CRC incidence was approximately 2,194,143 cases, with a prevalence of 11,679,120 and 24,401,100 DALYs. Central Europe exhibited the highest burden, with incidence peaking among individuals aged 84 to 94 years. From 1990 to 2021, age-standardized incidence, mortality, and DALY rates for CRC showed upward trends, particularly among males. The analysis of risk factors across 21 GBD regions reveals significant regional disparities in the colorectal cancer (CRC) burden, with Central Europe showing the highest contribution from risk factors (305.66). Behavioral risks, such as smoking and high alcohol use, have the greatest impact, followed by dietary risks (particularly low whole grain intake and high processed meat consumption) and metabolic risks (including high BMI and high fasting plasma glucose). By 2051, the global ASIR, ASMR, and ASDR of CRC are projected to reach 18.21 (95% UI: 10.83-25.59), 7.10 (95% UI: 4.36-9.84), and 165.21 (95% UI: 102.48-227.93) per 100,000 population, respectively, with the burden remaining higher in males than in females. Conclusion: This study provides the most granular assessment of CRC burden to date, highlighting dietary policies and sex-specific interventions as priorities. Methodological advancements in projection modeling offer actionable insights for long-term public health planning.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.